Abstract
Electroporation phenomena can be traced back to the eighteenth century when red spots on human animal skin (Lichtenberg figures) were observed in the areas where electric fields were applied. Once the cause of this phenomenon was understood and control over the parameters that produce electric fields was achieved, a quick adoption of the use of pulsed electric fields to kill microbes was seen in the area of food and water sterilization. Biomedical applications soon followed where electric fields began to be used to control movement of biological material: cells were brought in close proximity and fused together through membrane destabilization (electrofusion), DNA material was introduced into cells through transient pores in the membrane (electrogenetherapy), and chemotherapeutic drugs were directly delivered to cells (electrochemotherapy). These applications fall under the energy regime known as reversible electroporation in which temporary cell membrane destabilization is achieved. Irreversible electroporation (IRE) uses an energy regime much higher than that of reversible electroporation and induces cell death via various mechanisms. Since the postulation that IRE can be used to ablate substantial volumes in such a manner that it does not induce significant traditional thermal damage, it has been widely investigated moving from in vitro studies, to in vivo animal studies, and finally to human patients through clinical trials. Its nonthermal mechanism to induce cell death makes it an attractive modality to safely treat unresectable tumors.
Similar content being viewed by others
References
Reilly JP. Applied bioelectricity: from electrical stimulation to electropathology. New York: Springer; 1998.
Prausnitz MR. A practical assessment of transdermal drug delivery by skin electroporation. Adv Drug Deliv Rev. 1999;35:61–76.
Vanbever R, Préat V. In vivo efficacy and safety of skin electroporation. Adv Drug Deliv Rev. 1999;35:77–88.
Noad HM. Lectures on electricity; comprising galvanism, magnetism, electro-magnetism, magneto- and thermo- electricity, and electo-physiology. 3rd ed. London: George Knight and Sons; 1849.
Fuller GW. Report on the investigations into the purification of the Ohio river water at Louisville Kentucky. New York: D. Van Nostrand Company; 1898.
Rockwell AD. The medical and surgical uses of electricity: including the X-ray, Finsen light, vibratory therapeutics, and high-frequency currents. New York: E.B. Treat & Company; 1903.
Abidor IG, Li LH, Hui SW. Studies of cell pellets: II. Osmotic properties, electroporation, and related phenomena: membrane interactions. Biophys J. 1994;67:427–35.
Jex-Blake AJ. Death by electric currents and by lightning. The Goulstonian lectures for 1913. Br Med J. 1913;11:425–552., 492–498, 548–552, 601–603.
O’Keefe Gatewood M, Zane RD. Lightning injuries. Emerg Med Clin North Am. 2004;22:369–403.
McKinley GM. Short electric wave radiation in biology. In: Duggar BM, editor. Biological effects of radiation, vol. 1. New York: McGraw-Hill Book Co; 1936. p. 541–58.
Nyrop JE. A specific effect of high-frequency electric currents on biological objects. Nature. 1946;157:51–2.
Hodgkin AL. The ionic basis of electrical activity in nerve and muscle. Biol Rev Camb Philos Soc. 1951;26:339–409.
Frankenhaeuser B, Widén L. Anode break excitation in desheathed frog nerve. J Physiol. 1956;131:243–7.
Biedermann W. Electro-physiology, vol. 2. London: Macmillan; 1898.
Stämpfli R, Willi M. Membrane potential of a Ranvier node measured after electrical destruction of its membrane. Exp Dermatol. 1957;13:297–8.
Stämpfli R. Reversible electrical breakdown of the excitable membrane of a Ranvier node. An Acad Bras Cienc. 1957;30:57–63.
Doevenspeck H. Influencing cells and cell walls by electrostatic impulses. Fleishwirtshaft. 1961;13:986–7.
Sale AJH, Hamilton WA. Effects of high electric fields on microorganisms. 1. Killing of bacteria and yeasts. Biochim Biophys Acta. 1967;148:781–8.
Hamilton WA, Sale AJH. Effects of high electric fields on microorganisms. 2. Mechanism of action of the lethal effect. Biochim Biophys Acta. 1967;148:789–800.
Sale AJH, Hamilton WA. Effects of high electric fields on microorganisms. 3. Lysis of erythrocytes and protoplasts. Biochim Biophys Acta. 1968;163:37–43.
Zimmermann U, Pilwat G, Riemann F. Dielectric breakdown of cell membranes. Biophys J. 1974;14:881–99.
Riemann F, Zimmermann U, Pilwat G. Release and uptake of haemoglobin and ions in red blood cells induced by dielectric breakdown. Biochim Biophys Acta. 1975;394:449–62.
Kinosita KJ, Tsong TY. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature. 1977;268:438–41.
Belov SV. Effects of high-frequency current parameters on tissue coagulation. Biomed Eng. 1978;12:209–11.
Zimmermann U. Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta. 1982;694:227–77.
Neumann E, Schaeffer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lymphoma cells by electroporation in high electric fields. EMBO J. 1982;1:841–5.
Potter H, Weir L, Leder P. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A. 1984;81:7161–5.
Orlowskim S, Belehradek JJ, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 1988;34:4727–33.
Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res. 1987;78:1319–21.
Lee RC, Kolodney MS. Electrical injury mechanisms: electrical breakdown of cell membranes. Plast Reconstr Surg. 1987;80:672–9.
Lee RC, Gaylor DC, Bhatt D, Israel DA. Role of cell membrane rupture in the pathogenesis of electrical trauma. J Surg Res. 1988;44:709–19.
Powell KT, Morgenthaler AW, Weaver JC. Tissue electroporation. Observation of reversible electrical breakdown in viable frog skin. Biophys J. 1989;56:1163–71.
Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta. 1991;1088:131–4.
Mir LM, Orlowski S, Belehradek JJ, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer. 1991;27:68–72.
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek JJ, et al. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III. 1991;313:613–8.
Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A. 1993;90:10504–8.
Bhatt DL, Gaylor DC, Lee RC. Rhabdomyolysis due to pulsed electric fields. Plast Reconstr Surg. 1990;86(1):1–11., pp. 1–11.
Abramov GS, Bier M, Capelli-Schellpfeffer M, Lee RC. Alteration in sensory nerve function following electrical shock. Burns. 1996;22:602–6.
Bier M, Hammer SM, Canaday DJ, Lee RC. Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells. Bioelectromagnetics. 1999;20:194–201.
Lee RC, River LP, Pan FS, Ji L, Wollmann RL. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A. 1992;89:4524–8.
Piñero J, Lopez-Baena M, Ortiz T, Cortes F. Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells. Apoptosis. 1997;2:330–6.
Schoenbach KH, Peterkin FE, Alden RWI, Beebe SJ. The effect of pulsed electric fields on biological cells: experiments and applications. IEEE Trans Plasma Sci. 1997;25:284–92.
Schoenbach KH, Beebe SJ, Buescher ES. Intracellular effect of ultrashort electrical pulses. Bioelectromagnetics. 2001;22:440–8.
Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J. 1998;74:2152–8.
Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, et al. Electrochemotherapy on liver tumours in rabbits. Br J Cancer. 1998;77:2104–11.
Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta. 2002;1569:51–8.
Al-Khadra A, Nikolski V, Efimov IR. The role of electroporation in defibrillation. Circ Res. 2000;87:797–804.
Davalos RV, Rubinsky B. Tissue ablation with irreversible electroporation. US Application 10/571,162. Filed: 12/24/04 Issued 11/1/11 Patent No. 8,048,067. 2004.
Yao C, Sun C, Mi Y, Xiong L, Wang S. Experimental studies on killing and inhibiting effects of steep pulsed electric field (SPEF) to target cancer cell and solid tumor. IEEE Trans Plasma Sci. 2004;32:1626–33.
Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223.
Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality – clinical implications. Technol Cancer Res Treat. Feb 2007;6:37–48.
Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat. 2007;6:275–86.
Al-Sakere B, Bernat C, Andre F, Connault E, Opolon P, Davalos RV, et al. A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat. 2007;6:301–6.
Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PLoS One. 2007;2:e1135.
Lavee J, Onik G, Mikus P, Rubinsky B. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg Forum. 2007;10:E162–7.
Onik G, Rubinsky B, editors. Irreversible electroporation: first patient experience focal therapy of prostate cancer (irreversible electroporation). Berlin: Springer; 2010. p.^pp. Pages
Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22:611–21.
Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262:486–94.
Nollet JA. Recherches sur les causes particulieres des phénoménes électriques. Paris: Chez H.L. Guerin & L.F. Delatour; 1754.
Ivorra A, Rubinsky B. Historical review of irreversible electroporation in medicine. In: Boris Rubinsky, editor. Irreversible electroporation. Springer, Berlin; 2010. p. 1–21.
Malik MA, Ghaffar A, Malik SA. Water purification by electrical discharges. Plasma Sources Sci Technol. 2001;10:82.
Eliasson B, Hirth M, Kogelschatz U. Ozone synthesis from oxygen in dielectric barrier discharges. J Phys D Appl Phys. 1987;20:1421.
Liu C, Xie X, Zhao W, Liu N, Maraccini PA, Sassoubre LM, et al. Conducting nanosponge electroporation for affordable and high-efficiency disinfection of bacteria and viruses in water. Nano Lett. 2013;13:4288–93.
Liu C, Xie X, Zhao W, Yao J, Kong D, Boehm AB, et al. Static electricity powered copper oxide nanowire microbicidal electroporation for water disinfection. Nano Lett. 2014;14:5603–8.
Toepfl S, Mathys A, Heinz V, Knorr D. Review: potential of high hydrostatic pressure and pulsed electric fields for energy efficient and environmentally friendly food processing. Food Rev Intl. 2006;22:405–23.
Saulis G. Electroporation of cell membranes: the fundamental effects of pulsed electric fields in food processing. Food Eng Rev. 2010;2:52–73.
Mahnič-Kalamiza S, Vorobiev E, Miklavčič D. Electroporation in food processing and biorefinery. J Membr Biol. 2014;247:1279–304.
Burton H. A survey of literature on bacterial effects of short electromagnetic waves. Shinfield: National Institute for Research in Dairying; 1949.
Maxwell JC. A treatise on electricity and magnetism. 3rd ed. Oxford: Clarendon Press; 1904.
Cole KS. Electric impedance of suspensions of spheres. J Gen Physiol. 1928;12:29–36.
Miklavcic D, Kotnik T. Electroporation for electrochemotherapy and gene therapy. In: Rosch PJ, Markov MS, editors. Bioelectromagnetic medicine. New York: Informa Health Care; 2004. p. 637–56.
Neumann E, Rosenheck K. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol. 1972;29:279–90.
Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer. 1993;72:3694–700.
Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (EJSO). 2013;39:4–16.
Queirolo P, Marincola F, Spagnolo F. Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy. Arch Dermatol Res. 2014;306:521–6.
Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online. 2014;13:29.
Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–24.
Blagus T, Markelc B, Cemazar M, Kosjek T, Preat V, Miklavcic D, et al. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery. J Control Release. 2013;172:862–71.
Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer. 1999;35:672–7.
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer. 2008;98:388–98.
Rubinsky B, Edd J, Horowitz L. Electroporation to interrupt blood flow. USA Patent 12/163727. 2004.
Palanker D, Vankov A, Freyvert Y, Huie P. Pulsed electrical stimulation for control of vasculature: temporary vasoconstriction and permanent thrombosis. Bioelectromagnetics. 2008;29:100–7.
Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry. 2001;53:1–10.
Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 2012;72:1336–41.
Frandsen SK, Gissel H, Hojman P, Eriksen J, Gehl J. Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions. Biochim Biophys Acta (BBA) Gen Subj. 2014;1840:1204–8.
Hansen EL, Sozer EB, Romeo S, Frandsen SK, Vernier PT, Gehl J. Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One. 2015;10:e0122973.
Neumann E, Sowers AE, Jordan CA, editors. Electroporation and electrofusion in cell biology. New York: Plenum Press; 1989. p.^pp. Pages
Kanduser M, Usaj M. Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines. Expert Opin Drug Deliv. 2014;11:1885–98.
Nickoloff JA, editor. Electroporation protocols for microorganisms. Totowa: Humana Press; 1995. p.^pp. Pages
Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol. 2008;26:5896–903.
Tamura T, Sakata T. Application of in vivo electroporation to cancer gene therapy. Curr Gene Ther. 2003;3:59–64.
Jaroszeski MJ, Gilbert R, Nicolau C, Heller R. Delivery of genes in vivo using pulsed electric fields. Methods Mol Med. 2000;37:173–86.
Mir LM, Moller PH, André F, Gehl J. Electric pulse-mediated gene delivery to various animal tissues. Adv Genet. 2005;54:83–114.
Andre F, Mir L. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther. 2004;11:S33–42.
Christie RV, Binger CA. An experimental study of Diathermy IV. Evidence for the penetration of high frequency currents through the living body. J Exp Med. 1927;46:715–34.
Weinberg ED, Ward GE. Diathermy and regeneration of bone. Arch Surg. 1934;28:1121–9.
Fricke H. A mathematical treatment of the electric conductivity and capacity of disperse systems. II. The capacity of a suspension of conducting spheroids surrounded by a non-conducting membrane for a current of low frequency. Phys Rev. 1925;26:678–81.
Crowley JM. Electrical breakdown of bimolecular lipid membranes as an electromechanical instability. Biophys J. 1973;13:711–24.
Hofmann F, Ohnimus H, Scheller C, Strupp W, Zimmermann U, Jassoy C. Electric field pulses can induce apoptosis. J Membr Biol. 1999;169:103–9.
Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta. 2000;1523:73–83.
Edd J, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In-vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng. 2006;53:1409–15.
Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6:307–12.
Maor E, Ivorra A, Leor J, Rubinsky B. Irreversible electroporation attenuates neointimal formation after angioplasty. IEEE Trans Biomed Eng. 2008;55:2268–74.
Onik G, Rubinsky B, Mikus P. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat. 2007;6:295–300.
Gonzalez CA, Rojas R, Villanueva C, Rubinsky B. Inductive phase shift spectroscopy for volumetric brain edema detection: an experimental simulation. 2007 Ann Int Conf IEEE Eng Med Biol Soc. 2007;1–16:2346–9.
Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver. 2010;4(Suppl 1):S99–s104.
Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255:426–33.
Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, Daniel GB, et al. Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat. 2011;10:73–83.
Neal RE 2nd, Rossmeisl JH Jr, Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV. Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol. 2011;29:e372–7.
Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC 2nd. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2013;107:544–9.
Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol. 2012;23:1613–21.
Martin RC 2nd, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215:361–9.
Martin RC, Philips P, Ellis S, Hayes D, Bagla S. Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation. BMC Cancer. 2014;14:1–9.
Martin RC 2nd, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2013;20(Suppl 3):S443–9.
Bagla S, Papadouris D. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. J Vasc Intervent Radiol JVIR. 2012;23:142–5.
Scheffer HJ, Melenhorst MCAM, Vogel JA, van Tilborg AAJM, Nielsen K, Kazemier G, et al. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report. Cardiovasc Intervent Radiol. 2014;38:760–5.
Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol. 2011;34:132–8.
Trimmer CK, Khosla A, Morgan M, Stephenson SL, Ozayar A, Cadeddu JA. Minimally invasive percutaneous treatment of small renal tumors with irreversible electroporation: a single-center experience. J Vasc Interv Radiol. 2015;26:1465–71.
Narayanan G, Doshi MH. Irreversible Electroporation (IRE) in renal tumors. Curr Urol Rep. 2016;17:1–7.
Wendler JJ, Porsch M, Nitschke S, Kollermann J, Siedentopf S, Pech M, et al. A prospective phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials. 2015;43:10–9.
Wagstaff PG, de Bruin DM, Zondervan PJ, Savci Heijink CD, Engelbrecht MR, van Delden OM, et al. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer. 2015;15:165.
Wendler JJ, Ricke J, Pech M, Fischbach F, Jürgens J, Siedentopf S, et al. First delayed resection findings after Irreversible Electroporation (IRE) of human localised renal cell carcinoma (RCC) in the IRENE pilot phase 2a trial. Cardiovasc Intervent Radiol. 2015;39:239–50.
Deipolyi AR, Golberg A, Yarmush ML, Arellano RS, Oklu R. Irreversible electroporation: evolution of a laboratory technique in interventional oncology. Diagn Interv Radiol. 2014;20:147–54.
Bunte MC, Infante de Oliveira E, Shishehbor MH. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon. JACC Cardiovasc Interv. 2013;6:1–9.
Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 373:1275–81.
Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS One. 2009;4:e4757.
Maor E, Ivorra A, Mitchell JJ, Rubinsky B. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol. 2010;21:1708–15.
Baah-Dwomoh A, Rolong A, Gatenholm P, Davalos R. The feasibility of using irreversible electroporation to introduce pores in bacterial cellulose scaffolds for tissue engineering. Appl Microbiol Biotechnol. 2015;99:4785–4794., pp. 1–10.
Sano M, Neal R, Garcia P, Gerber D, Robertson J, Davalos R. Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online. 2010;9:83.
Golberg A, Broelsch GF, Bohr S, Mihm MC, Austen WG, Albadawi H, et al. Non-thermal, pulsed electric field cell ablation: a novel tool for regenerative medicine and scarless skin regeneration. Technology. 2013;1:1–7.
Golberg A, Khan S, Belov V, Quinn KP, Albadawi H, Felix Broelsch G, et al. Skin rejuvenation with non-invasive pulsed electric fields. Sci Rep. 2015;5:10187., 05/12/online.
Golberg A, Bruinsma BG, Jaramillo M, Yarmush ML, Uygun BE. Rat liver regeneration following ablation with irreversible electroporation. Peer J. 2016;4:e1571.
Golberg A, Broelsch GF, Vecchio D, Khan S, Hamblin MR, Austen WG Jr, et al. Eradication of multidrug-resistant A. baumannii in burn wounds by antiseptic pulsed electric field. Technology. 2014;2:153–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Rolong, A., Davalos, R.V., Rubinsky, B. (2018). History of Electroporation. In: Meijerink, M., Scheffer, H., Narayanan, G. (eds) Irreversible Electroporation in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-55113-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-55113-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55112-8
Online ISBN: 978-3-319-55113-5
eBook Packages: MedicineMedicine (R0)